Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-011479)

Filing Details

Accession Number:: 0001179110-17-011479
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-14 20:00:33
Reporting Period:: 2017-08-11

Filing Date:: 2017-08-14
Accepted Time:: 2017-08-14 20:00:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233438	M George Whitesides	C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2017-08-11	4,000	$24.69	4,000	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	184,392	Direct
Ordinary Shares	48,662	Indirect	By Family Trust